Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
537.00    4.00 (0.75%)
Bid:
536.00
Ask:
540.00
Spread: 4.00 (0.746%)
Market Cap: £309.39m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

28 Jul 2022 07:00

RNS Number : 9812T
Mortgage Advice Bureau (Hldgs) PLC
28 July 2022
 

28 July 2022

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1) today issues a trading update for the six months ended 30 June 2022, ahead of publishing its interim results on 27 September 2022.

Group revenue for the six months ended 30 June 2022 increased to circa £95m (H1 2021: £92m), up 3% on a comparative period in which mortgage completions had been considerably boosted by the stamp duty holiday changes at the end of March and June 2021.

The average number of mainstream1 advisers during the period increased by 19% to 1,890 (H1 2021: 1,584) with total adviser numbers as at 30 June 2022 up 8% to 2,0342 (31 December 2021: 1,885).

During the first half, the time taken to complete a property purchase increased by approximately one month compared to H1 2021. A number of factors have been delaying transactions, including conveyancing and local authority capacity constraints, down-valuations and expiring mortgage offers that need to be reconsidered and reissued by lenders due to the frequency of UK base rate increases in the period.

Despite the rising cost of living for UK households and further national and geopolitical uncertainty, the level of consumer demand for housing remains strong.

The resilience of demand from people moving home is supported by UK full employment, high levels of household savings and, for those who are subsequent movers, rising housing equity levels over recent years. Lenders also have strong liquidity levels, meaning mortgage availability is now close to pre-pandemic highs, thereby helping market activity to remain healthy.

Although interest rates have risen and will most likely continue to rise over the next 12 months, current interest rates remain near historical lows. As anticipated, increases in interest rates have stimulated more refinancing activity, with mortgage borrowers now more motivated than ever to secure the best possible rate to help their household budgeting. 

1 Excludes directly authorised advisers, later life advisers, and advisers from associates in the process of being onboarded under MAB's AR arrangements.

2 Includes a total of 67 advisers at 30 June 2022 who are either directly authorised or later life advisers. The directly authorised advisers are employees of a firm previously authorised under an Appointed Representative agreement with MAB until 7 December 2020. MAB will continue to provide services to this firm, which is now directly authorised by the FCA. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB. Also includes 14 advisers from associates, who are in the process of being onboarded under MAB's AR arrangements. These advisers will shortly become mainstream advisers. Until these 14 advisers become onboarded fully as mainstream advisers, MAB currently only recognises its share of profit after tax from these associates.

 

Current trading

The Group has started H2 2022 with a larger than usual pipeline of written business, due to the extended timeframe for completion of housing purchase transactions, and refinancing activity continues to be strong. Whilst we expect consumer demand to cool a little over the coming months, transaction levels are expected to remain healthy.

We were delighted to complete the acquisition of The Fluent Money Group earlier this month, which will allow the enlarged Group to benefit from national lead generation across our entire business sooner than initially anticipated. This reinforces our confidence in the outlook for 2023 and beyond.

Following the period end, the Group increased its stake from 49% to 75% in Vita Financial Limited, a leading protection and general insurance advice firm. This is a strategically important step for the Group as we look to achieve an even stronger market presence in this area.

The Group's adjusted profit before tax for the year ending 31 December 2022 is expected to be in line with market expectations.

Peter Brodnicki, CEO of MAB, commented:

"Despite the obvious frustrations with the pace of completion of housing purchase transactions, our growth plans have been further boosted this year by the acquisition of Fluent Money.

"The expected performance of this strong business, and the leverage it will provide to drive new and significant lead flow into MAB, added to continued strong adviser growth and ongoing enhancements in our technology platform, further supports our plan for accelerated growth into 2023 and beyond regardless of market conditions."

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Giles Rolls

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIRDIIDFIF
Date   Source Headline
13th Jul 20235:03 pmRNSBlock listing Interim Review
11th Jul 20237:00 amRNSDirectors' Shareholdings and PDMR notification
30th Jun 202312:08 pmRNSDirector/PDMR Shareholding
16th Jun 202311:49 amRNSDirector/PDMR Shareholding
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding
24th May 20235:16 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
16th May 20232:23 pmRNSPDMR Dealing and Total Voting Rights
28th Apr 20231:53 pmRNSDirectors' Shareholdings and PDMR notification
27th Apr 20234:39 pmRNSNotification of major holdings
20th Apr 20234:29 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 20235:08 pmRNSPDMR dealing and Total Voting Rights
31st Mar 20232:25 pmRNSDirectors' Shareholdings and PDMR notification
28th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
14th Mar 20235:05 pmRNSDirectors' Shareholdings and PDMR notification
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:35 pmRNSNon-Executive Director Board change
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20231:54 pmRNSDirectors' Shareholdings and PDMR notification
24th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20235:06 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
31st Jan 20237:00 amRNSTrading Update
17th Jan 20234:07 pmRNSDirectors' Shareholdings and PDMR notification
3rd Jan 20239:54 amRNSDirector's Shareholdings and PDMR notification
21st Dec 20227:00 amRNSAppointment of Joint Broker
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20221:51 pmRNSDirectors' Shareholdings and PDMR notification
1st Dec 20227:00 amRNSTrading Update
30th Nov 20224:50 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20224:15 pmRNSPDMR dealing notification and Total Voting Rights
7th Nov 20225:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Oct 20221:18 pmRNSDirectors' Shareholdings and PDMR notification
14th Oct 20225:04 pmRNSDirectors' Shareholdings and PDMR notification
6th Oct 20225:16 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSDirectors' Shareholdings and PDMR notification
4th Oct 20224:27 pmRNSHolding(s) in Company
3rd Oct 20225:13 pmRNSTotal Voting Rights
3rd Oct 20225:11 pmRNSHolding(s) in Company
30th Sep 202210:21 amRNSDirectors' Shareholdings and PDMR notification
27th Sep 20227:00 amRNSInterim Results
16th Sep 202210:36 amRNSDirectors' Shareholdings and PDMR notification
31st Aug 202212:53 pmRNSDirectors' Shareholdings and PDMR notification
16th Aug 202210:27 amRNSDirector/PDMR Shareholding
8th Aug 20224:36 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20221:03 pmRNSPDMR dealing notification and Total Voting Rights
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.